Alternative Data for Mind Medicine (MindMed)
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 82 | Sign up | Sign up | Sign up |
| Webpage traffic | 12,000 | Sign up | Sign up | Sign up |
| Employee Rating | 92 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 6,776 | Sign up | Sign up | Sign up |
| Instagram Followers | 18,865 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 95 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 26,085 | Sign up | Sign up | Sign up |
| X Followers | N/A | Sign up | Sign up | Sign up |
| X Mentions | 18 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 87 | Sign up | Sign up | Sign up |
About Mind Medicine (MindMed)
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness.
| Price | $15.02 |
| Target Price | Sign up |
| Volume | 2,050,000 |
| Market Cap | $1.46B |
| Year Range | $0.69 - $15.02 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Drug Manufacturers |
In the news
 |
Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 14 - SeekingAlpha |
Definium Therapeutics Announces New Employee Inducement GrantsJanuary 26 - Financial Post |
|
2026 Asset Growth: Why Federal Compliance Is the New MetricJanuary 19 - Financial Post |
|
Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol “DFTX” Effective January 15, 2026January 13 - Financial Post |
|
MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026January 12 - Financial Post |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 0 | 0 | 0 | -67M | -66M | -0.780 |
| Q2 '25 | 0 | 0 | 0 | -43M | -40M | -0.500 |
| Q1 '25 | 0 | 0 | 0 | -23M | -23M | -0.350 |
| Q4 '24 | 0 | 0 | 0 | -35M | -34M | -0.410 |
| Q3 '24 | 0 | 0 | 0 | -14M | -1.1M | -0.270 |
Insider Transactions View All
| Karlin Daniel filed to sell 425,025 shares at $13.1. December 29 '25 |
| Barrow Robert filed to sell 778,477 shares at $13.1. December 29 '25 |
| Sullivan Mark filed to sell 282,576 shares at $13.1. December 29 '25 |
| Sullivan Mark filed to sell 293,852 shares at $9.8. September 26 '25 |
| Barrow Robert filed to sell 804,268 shares at $9.8. September 26 '25 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$224.44 1.3% | 44 |
 |
Eli Lilly and CompanyLLY |
$1039.51 2.2% | 62 |
 |
PfizerPFE |
$26.5 2.4% | 51 |
 |
AstrazenecaAZN |
$95.6 1.5% | 49 |
 |
AbbVieABBV |
$223.93 1.4% | 53 |
Read more about Mind Medicine (MindMed) (MNMD) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, news mentions, customer reviews & business outlook.
FAQ - Mind Medicine (MindMed)
The Market Cap of Mind Medicine (MindMed) is $1.46B.
Currently, the price of one share of Mind Medicine (MindMed) stock is $15.02.
The MNMD stock price chart above provides a comprehensive visual representation of Mind Medicine (MindMed)'s stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Mind Medicine (MindMed) shares. Our platform offers an up-to-date MNMD stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Mind Medicine (MindMed) (MNMD) does not offer dividends to its shareholders. Investors interested in Mind Medicine (MindMed) should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Mind Medicine (MindMed) are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
